3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia

Cytogenetics and Cell Genetics

Volumn 74, Issue 4, 1996, Pages 295-299

  Shi, G ^a   Weh, H J ^a   Martensen, S ^a   Seeger, D ^a   Hossfeld, D K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; HYDROXYUREA; MELPHALAN; MERCAPTOPURINE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CHROMOSOME 3P; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; DRUG INDUCED DISEASE; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; MYELODYSPLASTIC SYNDROME; POLYCYTHEMIA VERA; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; TRANSLOCATION, GENETIC;

EID: 0029827390     PISSN: 03010171     EISSN: 1424859X     Source Type: Journal    
DOI: 10.1159/000134439     Document Type: Article

References (49)

1. Arthur DC, Bloomfield CD: Banded chromosome analysis in patients with treated-associated acute non-lymphocvtic leukemia, Cancer Genet Cytogcnct 12:189-199 (1984).
2. Barbata G, Carbone P, Mirto S, Santoro A, Giglio MC, Granata G: Translocation I (8;t6) (pll;pl3) in acute nonlymphocytic leukemia (M4) possibly secondary to Hodgkin's disease, Cancer Genet Cyto-genct 37:127-131 (1989).
3. Benitez J, Carbonell F, Ferro T, Prieto F, Fayos JS: Cytogenetic studies in 18 patients with secondary blood disorders, Cancer Genet Cytogenel 22:309-317 (1986).
4. Bennett JA, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia, Ann Intern Med 103:626-629 (1985).
5. Bloomfield CD: Chromosome abnormalities in secondary myelodysplastic syndromes, Scand J Haematol Suppl 45:82-90 (1986).
6. Bloomfield CD, Garson OM, Volin L, Knuutila S, de la Chapelle A: T (1;3) (p36;q21) in acute nonlymphocytic leukemia: A new clinicopathologic association (letter), Blood 68:320-322 (1986).
7. Carbone P, Santoro A, Giglio MC, Mirto S, Granata G: Cytogenetic findings in secondary acute nonlymphocytic leukemia, Cancer Genet Cytogenet 58:18-23 (1992).
8. de la Chapelle A, Knuutila S, Elonen F: Translocation (2:11) (p21;q23) in acute nonlymphocytic leukemia: a non-random association, Scand J Haematol Suppl 45:91-97 (1986).
9. Deborah PM, Symmons MB: Neoplasms of the immune system in rheumatoid arthritis, Am J Med 78 (suppl IA):22-28 (1985).
10. FIWCL (Fourth International Workshop on Chromosomes in Leukemia), 1982: Secondary leukemias associated with neoplasia: treated and untreated, Cancer Genet Cytogenet 11:319-321 (1984).
11. FIWCL (Forth International Workshop on Chromosomes in Leukemia), 1982: Clinical significance of chromosomal abnormalities in acute nonlympho-blaslic leukemia, Cancer Genet Cytogenet 11:332-350 (1984).
12. Fonatsch C, Burrichter H, Schaadt M, Kirchner HH, Diehl V: Translocation t (8;21) in peripheral lymphocytes and established lymphoid cell lines from a patient with Hodgkin's disease followed by acute lymphatic leukemia, Int J Cancer 30:321-327 (1982).
13. GFCHL (Groupe Français de Cytogenetique Hemalo-logique): Chromosome analysis of 63 cases of secondary nonlymphoid blood disorders: a cooperative study, Cancer Genet Cytogenet 12:95-104 (1984).
14. Greene MH, Boice JD Jr, Greer BE, Blessing JA, Dem-bo AJ: Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer, New Engl J Med 307:1416-1421 (1982).
15. Heim S, Mitelman F: Cancer Cytogenetics, (Alan R Liss, New York 1987).
16. ISCN (1995): An International System for Human Cytogenetic Nomenclature, Mitelman F (ed), (Karger, Basel 1995).
17. Ishihara T, Kohno S, Minamihisamatsu M: Radiation exposure and chromosome abnormalities: human cytogenetic studies at the national institute of radiological sciences, Japan, 1963-1988, Cancer Genet Cytogenet 45:13-33 (1990).
18. lurlo A, Mecucci C, Van Orshoven A, Michaux JL, Boogaerts M, Noens L, Boslv A, Louwagie A, Van den Bcrglic 11: Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome, Cancer Genet Cytogenet 43:227-241 (1989).
19. Klingelhutz A, Wu S, Bockland F.A, Rcznikoff CA, Allelic 3p deletions in high-grade carcinomas after transformation in vitro of human uroepithelial cells, Genes Chrom Cancer 3:346-357 (1991).
20. Knudson, AG: Antioncogenes and human cancer, Proc natl Acad Sci, USA 90:10914-10921 (1993).
21. Kok K, Hostra R, Pilz A, van den Bergh A, Terstra P, Buys Cl ICM, Carrilt B: A gene in the chromosomal region 3p21 with greatly reduced expression in lung cancer is similar to the gene for ubiquitin-acti-vating enzyme, Proc natl Acad Sci, USA 90:6071-6075 (1993).
22. Komblau SM, Goodac A, Cabanillas F: Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 14 cases from the literature, Hcmatol Oncol 9:63-78 (1991).
23. Larson RA, Le Beau MM, Vardiman JW, Testa JR, Golomb HM, Rowley JD: The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982), Cancer Genet Cytogenet 10:219-236 (1983).
24. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD: Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes No, 5 and 7, J Clin Oncol 3:325-345 (1986).
25. Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ: Second malignancies after treatment for laparotomy staged IA-II1B Hodgkin'sdis-ease: long-term analysis of risk factors and outcome, Blood 87:3625-3632 (1996).
26. Michels SD, McKenna RW, Arthur DC, Brunning RD: Therapy-related acute myeloid leukemia and myel-odysplastic syndrome: a clinical and morphologic study of 65 cases, Blood 65:1364-1372 (1985).
27. Mitelman F: Catalog of chromosome aberrations in cancer, Third edition, (Alan R Liss, New York 1988).
28. Naylor SL, Johnson BE, Minna JD, Sakaguchi AY: Loss of heterozygosity of chromosome 3p markers in small-cell-lung cancer, Nature 329:451-454 (1987).
29. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvilli Z, Mori M, McCue P, Druck T, Croce CM, Huebner K: The FHIT gene, spanning the chromosome 3pl4.2 fragile site and renal cell carcinoma-associated 1 (3:8) breakpoint, is abnormal in digestive tract cancers, Cell 84:587-597 (1996).
30. Panani A, Panayannis AG, Kyrkow K, Gardikas C: Cytogenetic studies in preleukemia using the G-banding staining technique, Scand J Haematol 18:301-308 (1977).
31. Pederscn-Bjergaard J, Larsen SO: Incidence of acute nonlvmphocytic leukemia, preleukemia, and acuie myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease, New Engl J Med 307:965-971 (1982).
32. Pedcrsen-Bjergaard J, Philip P, Ravn V, Hansen SW, Nissen NI: Therapy-rclaied acute nonlymphocytic leukemia of FAB type M4 or M5 with early onset and t (9:1 !Xp21:q23)or a normal karyotype: a separate eniity? [Icllcr], J Clin Oncol 6:395-7 (1988).
33. Polter AM, Watmore AE, Cooke P, Lillcyman JS, Sokcl RJ: Significance of non-slandard Philadelphia chromosomes in chronic granulocytic leukemia, Br J Haematol 44:51-54 (1981).
34. Pui C, Beltm FG, Raimondi S, Dodge RK, George SL, Rivera GK, Mirro J, Kalwinskv DK, Dahl GV, Murphy SB, Crisl WM, Williams DL: Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia, New Engl J Med 321:136-142 (1989).
35. Reimer RR, Hoover R, Fraumcni JF Jr, Young RC: Acute leukemia after alkylating-agent therapy of ovarian cancer, New Engl J Med 297:171-181 (1977).
36. Rosver F, Carey RW, Zarrabi MH: Brcasl cancer and acute leukemia: report of 24 cases and review of the literature, Am J Hcmalol 4:151-172 (1978).
37. Rowley JD, Golomb HM, Vardiman JW: Nonrandom chromosome abnormalities in acute leukemia and dysmyclopoietic syndromes in patients with previously treated malignant disease, Blood 58:759-767 (1981).
38. Rubin CM, Larson, RA, Anaslasi J, Winter JN, Than-gavelu M, Vardiman JW, Rowley JD, Le Beau MM: T (3;21Xq26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia, Blood 76:2594-2598 (1990).
39. Rubin CM, Arthur DC, Woods WG, Lange BJ, Nowell PC, Rowley JD, Nachman J, Bostrom B, Baum ES, Suarez CR, Shah NR, Morgan E, Maurer HS, McKenzie SE, Larson RA, Le Beau MM: Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalilies and prior therapy, Blood 78:2982-2988 (1991).
40. Sandberg AA, Abe S, Kowalczyk JR: Chromosomes and causation of human cancer and leukemia, I, Cytogenetics of leukemias complicating other diseases, Cancer Genet Cytogenet 7:95-136 (1982).
41. Schcres JMJC, Hustinx TWJ, Gcraedts JPM: Translocation (1;7) in hematological disorders: a brief review of 22 cases, Cancer Genet Cytogenet 18:207-213 (1985).
42. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotlicelli MG, Inoue H, Tondelli S, Piloni S, Dc Gregorio L, Pastorino U, Pierotti MA, Ohla M, Huebner K, Croce CM: The FHIT gene at 3pl4.2 is abnormal in lung cancer, Cell 85:17-26 (1996).
43. Tucker MA, Coleman CN, Cox RS, Varghcse A, Rosenberg SA: Risk of second cancers after ireatment for Hodgkin's disease, New Engl J Med 318:76-81 (1988).
44. Trent JM, Kaneko Y, Milclman F: Reports of the committee on structural chromosome changes in neoplasia, Cytogenet Cell Cytogenet 51:533-562 (1989).
45. Whang-Peng J, Knulsen T, O'Donnell JF, Brereton HD: Acute non-lymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia, Cancer 44:1592-1600 (1979).
46. Whang-Peng J, Young RC, Lee EC, Longo DL, Schechter GP, Devila VT: Cylogenelic studies in patients with secondary leukemia/dysmyelopoietic syndromes, Blood 71:403-413 (1988).
47. Whang-Peng J, Knulsen T, Gazdar A, Steinberg SM, Oie H, Linnoila I, Mulshine J, Nau M, Minna JD: Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer, Genes Chrom Cancer 3:168-188 (1991).
48. Well HJ, Hossfeld DK: 12p-chromosome in palients with acute myelocytic leukemia or myelodysplastic syndromes following exposure to mutagenic agents (letter), Cancer Genet Cviogenet 19:355-356 (1986).
49. Wilmoth D, Fcder M, Finan J, Nowell P: Preleukemia and leukemia with 12p- and I9q+ chromosome altera.ions following alkeran therapy, Cancer Gcn-etCytogcnet 15:95-98 (1985).